Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 212 entries
Sorted by: Best Match Show Resources per page
Strain in InP/ZnSe, S core/shell quantum dots from lattice mismatch and shell thickness-Material stiffness influence.

The Journal of chemical physics

Rafipoor M, Tornatzky H, Dupont D, Maultzsch J, Tessier MD, Hens Z, Lange H.
PMID: 31640388
J Chem Phys. 2019 Oct 21;151(15):154704. doi: 10.1063/1.5124674.

We investigate the buildup of strain in InP quantum dots with the addition of shells of the lower-lattice constant materials ZnSe and ZnS by Raman spectroscopy. Both materials induce compressive strain in the core, which increases with increasing shell...

Cite
Rafipoor M, Tornatzky H, Dupont D, et al. Strain in InP/ZnSe, S core/shell quantum dots from lattice mismatch and shell thickness-Material stiffness influence. J Chem Phys. 2019;151(15):154704doi: 10.1063/1.5124674.
Rafipoor, M., Tornatzky, H., Dupont, D., Maultzsch, J., Tessier, M. D., Hens, Z., & Lange, H. (2019). Strain in InP/ZnSe, S core/shell quantum dots from lattice mismatch and shell thickness-Material stiffness influence. The Journal of chemical physics, 151(15), 154704. https://doi.org/10.1063/1.5124674
Rafipoor, Mona, et al. "Strain in InP/ZnSe, S core/shell quantum dots from lattice mismatch and shell thickness-Material stiffness influence." The Journal of chemical physics vol. 151,15 (2019): 154704. doi: https://doi.org/10.1063/1.5124674
Rafipoor M, Tornatzky H, Dupont D, Maultzsch J, Tessier MD, Hens Z, Lange H. Strain in InP/ZnSe, S core/shell quantum dots from lattice mismatch and shell thickness-Material stiffness influence. J Chem Phys. 2019 Oct 21;151(15):154704. doi: 10.1063/1.5124674. PMID: 31640388.
Copy Download .nbib Format: NLM
Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional Survey.

The patient

Chow AJ, Pugliese M, Tessier LA, Chakraborty P, Iverson R, Coyle D, Kronick JB, Wilson K, Hayeems R, Al-Hertani W, Inbar-Feigenberg M, Jain-Ghai S, Laberge AM, Little J, Mitchell JJ, Prasad C, Siriwardena K, Sparkes R, Speechley KN, Stockler S, Trakadis Y, Walia JS, Wilson BJ, Potter BK.
PMID: 34282509
Patient. 2021 Jul 20; doi: 10.1007/s40271-021-00538-8. Epub 2021 Jul 20.

BACKGROUND AND OBJECTIVE: Children with inherited metabolic diseases often require complex and highly specialized care. Patient and family-centered care can improve health outcomes that are important to families. This study aimed to examine experiences of family caregivers (parents/guardians) of...

Cite
Chow AJ, Pugliese M, Tessier LA, et al. Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional Survey. Patient. 2021;doi: 10.1007/s40271-021-00538-8.
Chow, A. J., Pugliese, M., Tessier, L. A., Chakraborty, P., Iverson, R., Coyle, D., Kronick, J. B., Wilson, K., Hayeems, R., Al-Hertani, W., Inbar-Feigenberg, M., Jain-Ghai, S., Laberge, A. M., Little, J., Mitchell, J. J., Prasad, C., Siriwardena, K., Sparkes, R., Speechley, K. N., Stockler, S., Trakadis, Y., Walia, J. S., Wilson, B. J., & Potter, B. K. (2021). Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional Survey. The patient, . https://doi.org/10.1007/s40271-021-00538-8
Chow, Andrea J, et al. "Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional Survey." The patient vol. (2021). doi: https://doi.org/10.1007/s40271-021-00538-8
Chow AJ, Pugliese M, Tessier LA, Chakraborty P, Iverson R, Coyle D, Kronick JB, Wilson K, Hayeems R, Al-Hertani W, Inbar-Feigenberg M, Jain-Ghai S, Laberge AM, Little J, Mitchell JJ, Prasad C, Siriwardena K, Sparkes R, Speechley KN, Stockler S, Trakadis Y, Walia JS, Wilson BJ, Potter BK. Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional Survey. Patient. 2021 Jul 20; doi: 10.1007/s40271-021-00538-8. Epub 2021 Jul 20. PMID: 34282509; PMCID: PMC8289623.
Copy Download .nbib Format: NLM
MRI monitoring of transplanted neonatal porcine islets labeled with polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles in a mouse model.

Xenotransplantation

Purich K, Cai H, Yang B, Xu Z, Tessier AG, Black A, Hung RW, Boivin E, Xu B, Wu P, Zhang B, Xin D, Fallone BG, Rajotte RV, Wu Y, Rayat GR.
PMID: 34850455
Xenotransplantation. 2021 Nov 30; doi: 10.1111/xen.12720. Epub 2021 Nov 30.

Islet transplantation is a potential treatment option for certain patients with type 1 diabetes; however, it still faces barriers to widespread use, including the lack of tools to monitor islet grafts post-transplantation. This study investigates whether labeling neonatal porcine...

Cite
Purich K, Cai H, Yang B, et al. MRI monitoring of transplanted neonatal porcine islets labeled with polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles in a mouse model. Xenotransplantation. 2021;doi: 10.1111/xen.12720.
Purich, K., Cai, H., Yang, B., Xu, Z., Tessier, A. G., Black, A., Hung, R. W., Boivin, E., Xu, B., Wu, P., Zhang, B., Xin, D., Fallone, B. G., Rajotte, R. V., Wu, Y., & Rayat, G. R. (2021). MRI monitoring of transplanted neonatal porcine islets labeled with polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles in a mouse model. Xenotransplantation, . https://doi.org/10.1111/xen.12720
Purich, Kieran, et al. "MRI monitoring of transplanted neonatal porcine islets labeled with polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles in a mouse model." Xenotransplantation vol. (2021). doi: https://doi.org/10.1111/xen.12720
Purich K, Cai H, Yang B, Xu Z, Tessier AG, Black A, Hung RW, Boivin E, Xu B, Wu P, Zhang B, Xin D, Fallone BG, Rajotte RV, Wu Y, Rayat GR. MRI monitoring of transplanted neonatal porcine islets labeled with polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles in a mouse model. Xenotransplantation. 2021 Nov 30; doi: 10.1111/xen.12720. Epub 2021 Nov 30. PMID: 34850455.
Copy Download .nbib Format: NLM
Anxiety symptoms and disorders in the first year after sustaining mild traumatic brain injury.

Rehabilitation psychology

Lamontagne G, Belleville G, Beaulieu-Bonneau S, Souesme G, Savard J, Sirois MJ, Giguère M, Tessier D, Le Sage N, Ouellet MC.
PMID: 34843337
Rehabil Psychol. 2021 Nov 29; doi: 10.1037/rep0000422. Epub 2021 Nov 29.

PURPOSE/OBJECTIVE: The goals of the present study were (a) to document the prevalence of anxiety-related disorders and anxiety symptoms at 4, 8, and 12 months postinjury in individuals with mild traumatic brain injury (mTBI) while considering preinjury history of...

Cite
Lamontagne G, Belleville G, Beaulieu-Bonneau S, et al. Anxiety symptoms and disorders in the first year after sustaining mild traumatic brain injury. Rehabil Psychol. 2021;doi: 10.1037/rep0000422.
Lamontagne, G., Belleville, G., Beaulieu-Bonneau, S., Souesme, G., Savard, J., Sirois, M. J., Giguère, M., Tessier, D., Le Sage, N., & Ouellet, M. C. (2021). Anxiety symptoms and disorders in the first year after sustaining mild traumatic brain injury. Rehabilitation psychology, . https://doi.org/10.1037/rep0000422
Lamontagne, Guillaume, et al. "Anxiety symptoms and disorders in the first year after sustaining mild traumatic brain injury." Rehabilitation psychology vol. (2021). doi: https://doi.org/10.1037/rep0000422
Lamontagne G, Belleville G, Beaulieu-Bonneau S, Souesme G, Savard J, Sirois MJ, Giguère M, Tessier D, Le Sage N, Ouellet MC. Anxiety symptoms and disorders in the first year after sustaining mild traumatic brain injury. Rehabil Psychol. 2021 Nov 29; doi: 10.1037/rep0000422. Epub 2021 Nov 29. PMID: 34843337.
Copy Download .nbib Format: NLM
Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria.

Pediatrics

Pugliese M, Tingley K, Chow A, Pallone N, Smith M, Chakraborty P, Geraghty MT, Irwin JK, Mitchell JJ, Stockler S, Nicholls SG, Offringa M, Rahman A, Tessier LA, Butcher NJ, Iverson R, Lamoureux M, Clifford TJ, Hutton B, Paik K, Tao J, Skidmore B, Coyle D, Duddy K, Dyack S, Greenberg CR, Jain Ghai S, Karp N, Korngut L, Kronick J, MacKenzie A, MacKenzie J, Maranda B, Potter M, Prasad C, Schulze A, Sparkes R, Taljaard M, Trakadis Y, Walia J, Potter BK.
PMID: 34266901
Pediatrics. 2021 Aug;148(2). doi: 10.1542/peds.2020-037747. Epub 2021 Jul 15.

BACKGROUND: Evidence to guide treatment of pediatric medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency and phenylketonuria (PKU) is fragmented because of large variability in outcome selection and measurement. Our goal was to develop core outcome sets (COSs) for these diseases...

Cite
Pugliese M, Tingley K, Chow A, et al. Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria. Pediatrics. 2021;148(2)doi: 10.1542/peds.2020-037747.
Pugliese, M., Tingley, K., Chow, A., Pallone, N., Smith, M., Chakraborty, P., Geraghty, M. T., Irwin, J. K., Mitchell, J. J., Stockler, S., Nicholls, S. G., Offringa, M., Rahman, A., Tessier, L. A., Butcher, N. J., Iverson, R., Lamoureux, M., Clifford, T. J., Hutton, B., Paik, K., Tao, J., Skidmore, B., Coyle, D., Duddy, K., Dyack, S., Greenberg, C. R., Jain Ghai, S., Karp, N., Korngut, L., Kronick, J., MacKenzie, A., MacKenzie, J., Maranda, B., Potter, M., Prasad, C., Schulze, A., Sparkes, R., Taljaard, M., Trakadis, Y., Walia, J., Potter, B. K. (2021). Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria. Pediatrics, 148(2), . https://doi.org/10.1542/peds.2020-037747
Pugliese, Michael, et al. "Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria." Pediatrics vol. 148,2 (2021). doi: https://doi.org/10.1542/peds.2020-037747
Pugliese M, Tingley K, Chow A, Pallone N, Smith M, Chakraborty P, Geraghty MT, Irwin JK, Mitchell JJ, Stockler S, Nicholls SG, Offringa M, Rahman A, Tessier LA, Butcher NJ, Iverson R, Lamoureux M, Clifford TJ, Hutton B, Paik K, Tao J, Skidmore B, Coyle D, Duddy K, Dyack S, Greenberg CR, Jain Ghai S, Karp N, Korngut L, Kronick J, MacKenzie A, MacKenzie J, Maranda B, Potter M, Prasad C, Schulze A, Sparkes R, Taljaard M, Trakadis Y, Walia J, Potter BK. Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria. Pediatrics. 2021 Aug;148(2). doi: 10.1542/peds.2020-037747. Epub 2021 Jul 15. PMID: 34266901.
Copy Download .nbib Format: NLM
The effect of blood cells retained in rat livers during static cold storage on viability outcomes during normothermic machine perfusion.

Scientific reports

Haque O, Pendexter CA, Wilks BT, Hafiz EOA, Markmann JF, Uygun K, Yeh H, Tessier SN.
PMID: 34848781
Sci Rep. 2021 Nov 30;11(1):23128. doi: 10.1038/s41598-021-02417-6.

In transplantation, livers are transported to recipients using static cold storage (SCS), whereby livers are exposed to cold ischemic injury that contribute to post-transplant risk factors. We hypothesized that flushing organs during procurement with cold preservation solutions could influence...

Cite
Haque O, Pendexter CA, Wilks BT, et al. The effect of blood cells retained in rat livers during static cold storage on viability outcomes during normothermic machine perfusion. Sci Rep. 2021;11(1):23128doi: 10.1038/s41598-021-02417-6.
Haque, O., Pendexter, C. A., Wilks, B. T., Hafiz, E. O. A., Markmann, J. F., Uygun, K., Yeh, H., & Tessier, S. N. (2021). The effect of blood cells retained in rat livers during static cold storage on viability outcomes during normothermic machine perfusion. Scientific reports, 11(1), 23128. https://doi.org/10.1038/s41598-021-02417-6
Haque, Omar, et al. "The effect of blood cells retained in rat livers during static cold storage on viability outcomes during normothermic machine perfusion." Scientific reports vol. 11,1 (2021): 23128. doi: https://doi.org/10.1038/s41598-021-02417-6
Haque O, Pendexter CA, Wilks BT, Hafiz EOA, Markmann JF, Uygun K, Yeh H, Tessier SN. The effect of blood cells retained in rat livers during static cold storage on viability outcomes during normothermic machine perfusion. Sci Rep. 2021 Nov 30;11(1):23128. doi: 10.1038/s41598-021-02417-6. PMID: 34848781; PMCID: PMC8633375.
Copy Download .nbib Format: NLM
Agonist antibody discovery: Experimental, computational, and rational engineering approaches.

Drug discovery today

Schardt JS, Jhajj HS, O'Meara RL, Lwo TS, Smith MD, Tessier PM.
PMID: 34571277
Drug Discov Today. 2022 Jan;27(1):31-48. doi: 10.1016/j.drudis.2021.09.008. Epub 2021 Sep 24.

Agonist antibodies that activate cellular signaling have emerged as promising therapeutics for treating myriad pathologies. Unfortunately, the discovery of rare antibodies with the desired agonist functions is a major bottleneck during drug development. Nevertheless, there has been important recent...

Cite
Schardt JS, Jhajj HS, O'Meara RL, et al. Agonist antibody discovery: Experimental, computational, and rational engineering approaches. Drug Discov Today. 2021;27(1):31-48doi: 10.1016/j.drudis.2021.09.008.
Schardt, J. S., Jhajj, H. S., O'Meara, R. L., Lwo, T. S., Smith, M. D., & Tessier, P. M. (2022). Agonist antibody discovery: Experimental, computational, and rational engineering approaches. Drug discovery today, 27(1), 31-48. https://doi.org/10.1016/j.drudis.2021.09.008
Schardt, John S, et al. "Agonist antibody discovery: Experimental, computational, and rational engineering approaches." Drug discovery today vol. 27,1 (2022): 31-48. doi: https://doi.org/10.1016/j.drudis.2021.09.008
Schardt JS, Jhajj HS, O'Meara RL, Lwo TS, Smith MD, Tessier PM. Agonist antibody discovery: Experimental, computational, and rational engineering approaches. Drug Discov Today. 2022 Jan;27(1):31-48. doi: 10.1016/j.drudis.2021.09.008. Epub 2021 Sep 24. PMID: 34571277.
Copy Download .nbib Format: NLM
Oligator: a flexible interface to draw oligosaccharide structures and generate their theoretical tandem mass spectra.

Bioinformatics (Oxford, England)

Lollier V, Fanuel M, Ropartz D, Tessier D, Rogniaux H.
PMID: 34050747
Bioinformatics. 2021 May 29; doi: 10.1093/bioinformatics/btab412. Epub 2021 May 29.

SUMMARY: Oligator is software designed to assist scientists in their exploration of MS/MS experiments, especially for oligosaccharides bearing unreferenced chemical substitutions. Through a graphical interface, users have the total flexibility to build a candidate glycan structure and produce the...

Cite
Lollier V, Fanuel M, Ropartz D, et al. Oligator: a flexible interface to draw oligosaccharide structures and generate their theoretical tandem mass spectra. Bioinformatics. 2021;doi: 10.1093/bioinformatics/btab412.
Lollier, V., Fanuel, M., Ropartz, D., Tessier, D., & Rogniaux, H. (2021). Oligator: a flexible interface to draw oligosaccharide structures and generate their theoretical tandem mass spectra. Bioinformatics (Oxford, England), . https://doi.org/10.1093/bioinformatics/btab412
Lollier, Virginie, et al. "Oligator: a flexible interface to draw oligosaccharide structures and generate their theoretical tandem mass spectra." Bioinformatics (Oxford, England) vol. (2021). doi: https://doi.org/10.1093/bioinformatics/btab412
Lollier V, Fanuel M, Ropartz D, Tessier D, Rogniaux H. Oligator: a flexible interface to draw oligosaccharide structures and generate their theoretical tandem mass spectra. Bioinformatics. 2021 May 29; doi: 10.1093/bioinformatics/btab412. Epub 2021 May 29. PMID: 34050747.
Copy Download .nbib Format: NLM
Milk, Yogurt, and Cheese Intake Is Positively Associated With Cognitive Executive Functions in Older Adults of the Canadian Longitudinal Study on Aging.

The journals of gerontology. Series A, Biological sciences and medical sciences

Tessier AJ, Presse N, Rahme E, Ferland G, Bherer L, Chevalier S.
PMID: 34115853
J Gerontol A Biol Sci Med Sci. 2021 Nov 15;76(12):2223-2231. doi: 10.1093/gerona/glab165.

BACKGROUND: Dairy products provide essential nutrients such as calcium and vitamins B12 and D, and include bioactive peptides and fermented products, which may be beneficial for cognition, especially in older adults. Yet, few studies of large contemporary cohorts have...

Cite
Tessier AJ, Presse N, Rahme E, et al. Milk, Yogurt, and Cheese Intake Is Positively Associated With Cognitive Executive Functions in Older Adults of the Canadian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci. 2021;76(12):2223-2231doi: 10.1093/gerona/glab165.
Tessier, A. J., Presse, N., Rahme, E., Ferland, G., Bherer, L., & Chevalier, S. (2021). Milk, Yogurt, and Cheese Intake Is Positively Associated With Cognitive Executive Functions in Older Adults of the Canadian Longitudinal Study on Aging. The journals of gerontology. Series A, Biological sciences and medical sciences, 76(12), 2223-2231. https://doi.org/10.1093/gerona/glab165
Tessier, Anne-Julie, et al. "Milk, Yogurt, and Cheese Intake Is Positively Associated With Cognitive Executive Functions in Older Adults of the Canadian Longitudinal Study on Aging." The journals of gerontology. Series A, Biological sciences and medical sciences vol. 76,12 (2021): 2223-2231. doi: https://doi.org/10.1093/gerona/glab165
Tessier AJ, Presse N, Rahme E, Ferland G, Bherer L, Chevalier S. Milk, Yogurt, and Cheese Intake Is Positively Associated With Cognitive Executive Functions in Older Adults of the Canadian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci. 2021 Nov 15;76(12):2223-2231. doi: 10.1093/gerona/glab165. PMID: 34115853.
Copy Download .nbib Format: NLM
Metabolic transit of dietary advanced glycation end-products - the case of N.

Glycoconjugate journal

Tessier FJ, Boulanger E, Howsam M.
PMID: 32990827
Glycoconj J. 2021 Jun;38(3):311-317. doi: 10.1007/s10719-020-09950-y. Epub 2020 Sep 29.

The Maillard reaction, also called glycation, is one of the major chemical reactions responsible for most yellow-to-brown colors and aromas in cooked foods. This reaction between reducing sugars and amino functions on proteins affects not only the flavor of...

Cite
Tessier FJ, Boulanger E, Howsam M. Metabolic transit of dietary advanced glycation end-products - the case of N. Glycoconj J. 2020;38(3):311-317doi: 10.1007/s10719-020-09950-y.
Tessier, F. J., Boulanger, E., & Howsam, M. (2021). Metabolic transit of dietary advanced glycation end-products - the case of N. Glycoconjugate journal, 38(3), 311-317. https://doi.org/10.1007/s10719-020-09950-y
Tessier, Frederic J, et al. "Metabolic transit of dietary advanced glycation end-products - the case of N." Glycoconjugate journal vol. 38,3 (2021): 311-317. doi: https://doi.org/10.1007/s10719-020-09950-y
Tessier FJ, Boulanger E, Howsam M. Metabolic transit of dietary advanced glycation end-products - the case of N. Glycoconj J. 2021 Jun;38(3):311-317. doi: 10.1007/s10719-020-09950-y. Epub 2020 Sep 29. PMID: 32990827.
Copy Download .nbib Format: NLM
Optimization of Ex Vivo Machine Perfusion and Transplantation of Vascularized Composite Allografts.

The Journal of surgical research

Burlage LC, Lellouch AG, Taveau CB, Tratnig-Frankl P, Pendexter CA, Randolph MA, Porte RJ, Lantieri LA, Tessier SN, Cetrulo CL, Uygun K.
PMID: 34670191
J Surg Res. 2021 Oct 17;270:151-161. doi: 10.1016/j.jss.2021.09.005. Epub 2021 Oct 17.

BACKGROUND: Machine perfusion is gaining interest as an efficient method of tissue preservation of Vascularized Composite Allografts (VCA). The aim of this study was to develop a protocol for ex vivo subnormothermic oxygenated machine perfusion (SNMP) on rodent hindlimbs...

Cite
Burlage LC, Lellouch AG, Taveau CB, et al. Optimization of Ex Vivo Machine Perfusion and Transplantation of Vascularized Composite Allografts. J Surg Res. 2021;270:151-161doi: 10.1016/j.jss.2021.09.005.
Burlage, L. C., Lellouch, A. G., Taveau, C. B., Tratnig-Frankl, P., Pendexter, C. A., Randolph, M. A., Porte, R. J., Lantieri, L. A., Tessier, S. N., Cetrulo, C. L., & Uygun, K. (2021). Optimization of Ex Vivo Machine Perfusion and Transplantation of Vascularized Composite Allografts. The Journal of surgical research, 270151-161. https://doi.org/10.1016/j.jss.2021.09.005
Burlage, Laura C, et al. "Optimization of Ex Vivo Machine Perfusion and Transplantation of Vascularized Composite Allografts." The Journal of surgical research vol. 270 (2021): 151-161. doi: https://doi.org/10.1016/j.jss.2021.09.005
Burlage LC, Lellouch AG, Taveau CB, Tratnig-Frankl P, Pendexter CA, Randolph MA, Porte RJ, Lantieri LA, Tessier SN, Cetrulo CL, Uygun K. Optimization of Ex Vivo Machine Perfusion and Transplantation of Vascularized Composite Allografts. J Surg Res. 2021 Oct 17;270:151-161. doi: 10.1016/j.jss.2021.09.005. Epub 2021 Oct 17. PMID: 34670191.
Copy Download .nbib Format: NLM
Agonist antibody discovery: Experimental, computational, and rational engineering approaches.

Drug discovery today

Schardt JS, Jhajj HS, O'Meara RL, Lwo TS, Smith MD, Tessier PM.
PMID: 34571277
Drug Discov Today. 2022 Jan;27(1):31-48. doi: 10.1016/j.drudis.2021.09.008. Epub 2021 Sep 24.

Agonist antibodies that activate cellular signaling have emerged as promising therapeutics for treating myriad pathologies. Unfortunately, the discovery of rare antibodies with the desired agonist functions is a major bottleneck during drug development. Nevertheless, there has been important recent...

Cite
Schardt JS, Jhajj HS, O'Meara RL, et al. Agonist antibody discovery: Experimental, computational, and rational engineering approaches. Drug Discov Today. 2021;27(1):31-48doi: 10.1016/j.drudis.2021.09.008.
Schardt, J. S., Jhajj, H. S., O'Meara, R. L., Lwo, T. S., Smith, M. D., & Tessier, P. M. (2022). Agonist antibody discovery: Experimental, computational, and rational engineering approaches. Drug discovery today, 27(1), 31-48. https://doi.org/10.1016/j.drudis.2021.09.008
Schardt, John S, et al. "Agonist antibody discovery: Experimental, computational, and rational engineering approaches." Drug discovery today vol. 27,1 (2022): 31-48. doi: https://doi.org/10.1016/j.drudis.2021.09.008
Schardt JS, Jhajj HS, O'Meara RL, Lwo TS, Smith MD, Tessier PM. Agonist antibody discovery: Experimental, computational, and rational engineering approaches. Drug Discov Today. 2022 Jan;27(1):31-48. doi: 10.1016/j.drudis.2021.09.008. Epub 2021 Sep 24. PMID: 34571277; PMCID: PMC8714685.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 212 entries